What new in diagnostic and therapy type 1 diabetes? Part I

Ewa Otto-Buczkowska

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

1/2011
vol. 14

Send email

Copy url:

abstract:

What new in diagnostic and therapy type 1 diabetes? Part I

Ewa Otto-Buczkowska

Online publish date: 2011/03/17

View full text Get citation

Tightening of the diabetes control criteria in the last few years induces searches for adjunctive drugs to reinforce the basic treatment typical of the specific type of the disease. These agents are meant to stimulate insulin secretion, increase insulin sensitivity or inhibit the antagonists of the hormone. Up till now that kind of studies included adults, mainly with type 2 diabetes. Nowadays, however, the increasing number of research focus on type 1 diabetic patients. In recent years more and more frequently the method of multiple daily injections (MDI) of insulin is being replaced by the method of continuous subcutaneous insulin infusion (CSII). It is the most physiological way to administer insulin. Treatment with insulin pumps has been used more frequently in the pediatric patients and in the treatment of diabetes in pregnancy.

keywords:

What new in diagnostic and therapy type 1 diabetes? Part I

Ewa Otto-Buczkowska

diabetes type 1, basic treatment, adjunctive drugs, continuous subcutaneous insulin infusion (CSII), insulin pumps